drugset / Trial / NCT01140178
A Trial of Photodynamic Therapy With HPPH for Treatment of Dysplasia, Carcinoma in Situ and T1 Carcinoma of the Oral Cavity and/or Oropharynx
Phase 1
Completed
29 enrolled
Roswell Park Cancer Institute
National Cancer Institute (NCI) · collab
NaSingle-groupOpen-labelTreatment
Summary
Recent literature suggests that certain patients with squamous cell cancers of the head and neck region may benefit from photodynamic therapy whether or not they may have received prior therapy, e.g. radiation therapy
Timeline
- Start
- 2010-06-08
- Primary completion
- 2013-01-29
- Completion
- 2018-10-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 2-(1-HEXYLOXYETHYL)-2-DEVINYL PYROPHEOPHORBIDE-A | Unknown | 4 mg/m2 | Intravenous |